FDA Approved: PANRETIN — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approves Advanz Pharma US Corp's supplemental application for PANRETIN (alitretinoin). The approval may update labeling or add a new/expanded indication for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• PANRETIN (ALITRETINOIN)

Snippet

SUPPL AP for PANRETIN (ALITRETINOIN)